Journal Profile | |
Journal Title | LEUKEMIA & LYMPHOMA
|
Journal Title Abbreviations | LEUKEMIA LYMPHOMA |
ISSN | 1042-8194 |
E-ISSN | 1029-2403 |
h-index | 82 |
CiteScore | CiteScore | SJR | SNIP | CiteScore Rank |
---|
3.80 | 0.886 | 0.739 | Subject field | Quartiles | Rank | Percentile | Category: Medicine Subcategory: Hematology | Q2 | 54 / 123 |
| Category: Medicine Subcategory: Cancer Research | Q3 | 132 / 198 |
| Category: Medicine Subcategory: Oncology | Q2 | 162 / 331 |
|
|
|
Self-Citation Ratio (2019-2020) | 7.60% |
Official Website | http://informahealthcare.com/journal/lal |
Online Manuscript Submission | http://mc.manuscriptcentral.com/glal |
Open Access | No |
Publisher | TAYLOR & FRANCIS LTD, 4 PARK SQUARE, MILTON PARK, ABINGDON, ENGLAND, OXON, OX14 4RN |
Subject Area | Medicine |
Country/Area of Publication | ENGLAND |
Publication Frequency | Monthly |
Year Publication Started | 1989 |
Annual Article Volume | 323 |
Indexing (SCI or SCIE) | Science Citation Index Expanded
|
Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1042-8194%5BISSN%5D |
Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: Average 1.8 Month(s) |
Competitiveness * | Data from Authors: About 66.66% |
Useful Links | |
*All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. |